ADMA Biologics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ADMA Biologics, Inc. on December 18, 2023. The filing reports the entry into a new material definitive credit agreement and the simultaneous termination of a previous credit facility.
Key Financial Metrics and Debt Structure
The Company entered into a $130 million senior secured credit facility with Ares Capital Corporation and affiliated funds. The facility was fully drawn down on the closing date.
- Total Facility Size: $130,000,000
- Initial Term Loan: $62,500,000
- Revolving Credit Facility: Up to $72,500,000
- Maturity Date: December 20, 2027
- Interest Rates (Closing Date): 11.87774% for the Term Loan; 9.12774% for the Revolving Facility.
- Collateral: First-priority lien on substantially all tangible and intangible assets, including intellectual property and subsidiary equity.
Material Changes Versus Prior Period
The Company used the proceeds from the new Ares Credit Facilities, combined with cash on hand, to terminate and pay in full all outstanding obligations under its previous senior credit facility with Hayfin Services LLP. This transaction replaced the prior debt structure with the new Ares agreement.
Management Commentary, Covenants, and Risks
Future proceeds from the Ares Credit Facilities are designated for general corporate purposes. The agreement includes standard affirmative and negative covenants. Key financial covenants include:
- Minimum Liquidity Covenant: $15,000,000
- Leverage: Maximum total leverage ratios apply.
- Restrictions: Limits on incurring new indebtedness, creating liens, fundamental corporate changes, and restricted payments.
- Default Penalties: In the event of a default, applicable interest margins increase by an additional 2.0% per annum.
- Prepayment Terms: The Revolving Facility can be prepaid without a premium. The Term Loan prepayment is subject to a premium ranging from 1.0% to 1.5% of the principal plus the present value of remaining interest, depending on the timing relative to the closing date.
The filing text does not provide specific revenue, profit, or cash flow figures for the reporting period, as this is a transactional filing rather than a periodic financial report.
Investor Verification Checklist
- Verify the exact amount of cash on hand used alongside the new facility to pay off the Hayfin Credit Facility.
- Review the full text of the Credit Agreement (Exhibit 10.1) for specific definitions of "Maximum Total Leverage Ratios" and "Restricted Payments."
- Confirm the current adjusted Term SOFR rate to calculate the most up-to-date interest expense.
- Assess the impact of the new debt service obligations on the Company's future liquidity and operating cash flow.